MD-RACT

Mar 2020

Coronavirus | COVID-19 RACT Now Available

By |2020-05-13T14:33:20+00:00March 20, 2020|Blog, News|0 Comments

Cyntegrity developed a special COVID-19 RACT that guides those involved in clinical trials on specific risks which may arise as a result of COVID-19, and how they can mitigate them. This special RACT is part of the COVID-19 rapid deployment pack for ad-hoc centralized monitoring.

Feb 2020

Healthy Volunteers – Phase 1 RACT Now Available

By |2020-02-17T08:17:26+00:00February 11, 2020|Blog, News|0 Comments

The need for a controlled research environment adds another risk dimension to the Phase 1 study design. The new Healthy Volunteers - Phase 1 RACT serves as a helpful source to ensure maximum subject safety and a reliable outcome.

Sep 2018

3rd Annual Global Risk Based Monitoring Conference

By |2018-08-30T15:18:38+00:00September 13, 2018||Comments Off on 3rd Annual Global Risk Based Monitoring Conference

Sponsor, Speaker....and Many New Features to Demo With a surge of new technologies and trial models being implemented, the time is now to capitalise on industry expertise to capture the cost and efficiency benefits of risk-based monitoring. Join us in London for CBI’s 3rd annual Global [...]

Jul 2018

Press Release: Cyntegrity enters the Medical Devices Market

By |2019-04-02T11:07:31+00:00July 10, 2018|News|0 Comments

Cyntegrity today announced the worldwide release of their Medical Device RACT, “MD-RACT”, the world’s first Risk Assessment and Categorization Tool for clinical investigations, that combines the best practices in Life Sciences with subject matter expertise in Medical Devices.

Upcoming Events

  1. MyRBQM® Academy Alumni-Only Webcast

    May 27 @ 4:00 pm - 5:00 pm UTC+0
  2. 25th Annual GQMA Conference

    September 17 - September 18

Register Today!

Get Free Test Access